|
Clerk of the House of Representatives Legislative Resource Center 135 Cannon Building Washington, DC 20515 http://lobbyingdisclosure.house.gov |
Secretary of the Senate Office of Public Records 232 Hart Building Washington, DC 20510 http://www.senate.gov/lobby |
LOBBYING REGISTRATION
Lobbying Disclosure Act of 1995 (Section 4)
| 1. Effective Date of Registration | 2/1/2015 |
||||
| 2. House Identification | 36969 |
Senate Identification | 286096 |
||
REGISTRANT Organization/Lobbying Firm Self Employed Individual
| 3. Registrant | Organization | The McManus Group |
||||
| Address | 610 10th St NW |
Address2 | #300 |
| City | Washington |
State | DC |
Zip | 20001 |
Country | USA |
4. Principal place of business (if different than line 3)
| City |
|
State |
|
Zip |
|
Country |
|
| 5. Contact name and telephone number | International Number |
| Contact | Mr. Chase Thomas |
Telephone | 2023830085 |
cthomas@mcmanusgrp.com |
CLIENT A Lobbying Firm is required to file a separate registration for each client. Organizations employing in-house lobbyists should check the box labeled “Self” and proceed to line 10. Self
| 7. Client name | Novartis |
| Address | 701 Pennsylvania Ave. NW #725 |
| City | Washington |
State | DC |
Zip | 20004 |
Country | USA |
| City | Basel |
State |
|
Zip | 4056 |
Country | SUI |
LOBBYISTS
10. Name of each individual who has acted or is expected to act as a lobbyist for the client identified on line 7. If any person listed in this section has served as a “covered executive branch official” or “covered legislative branch official” within twenty years of first acting as a lobbyist for the client, state the executive and/or legislative position(s) in which the person served.
| Name | Covered Official Position (if applicable) | ||
First |
Last |
Suffix |
|
| John | McManus | | Staff Director W&M; LA, Rep. Bill Thomas |
| Barrett | Thornhill | | LA, Sen. Crapo & Rep. Toomey; LA & Press Sec. Rep. Norwood |
| | | | |
| | | | |
| | | | |
LOBBYING ISSUES
11. General lobbying issue areas (Select all applicable codes).
HCR |
TAX |
MMM |
|
|
|
|
|
|
12. Specific lobbying issues (current and anticipated)
TAX-legislation and regulations affecting taxation of pharmaceutical products, including research and development and orphan drug tax credits. HCR-- legislation and regulations affecting pharmaceutical coverage and payments in federal programs MMM -- Pharmaceutical coverage and access in Parts A, B, C, and D
AFFILIATED ORGANIZATIONS
13. Is there an entity other than the client that contributes more than $5,000 to the lobbying activities of the registrant in a quarterly period and either participates in and/or in whole or in major part supervises or controls the registrant’s lobbying activities?
| No --> Go to line 14. | Yes --> Complete the rest of this section for each entity matching the criteria above, then proceed to line 14. |
| Internet Address: |
|
| Name | Address | Principal Place of Business | ||||||||
| Street | ||||||||||
|
||||||||||
|
|
|
||||||||
|
|
|||||||||
|
|
|
||||||||
|
|
|||||||||
|
|
|
||||||||
|
|
FOREIGN ENTITIES
14. Is there any foreign entity
a) holds at least 20% equitable ownership in the client or any organization identified on line 13; or
b) directly or indirectly, in whole or in major part, plans, supervises, controls, directs, finances or subsidizes activities of the client or any organization identified on line 13; or
c) is an affiliate of the client or any organization identified on line 13 and has a direct interest in the outcome of the lobbying activity?
| No --> Sign and date the registration. | Yes --> Complete the rest of this section for each entity matching the criteria above, then sign the registration. |
| Address | Ownership | |||||
| Name | Street | Principal place of business | Amount of contribution | |||
|
(city and state or country) | for lobbying activities | ||||
Fabrikstrasse 2 |
|
|||||||||||
Novartis AG |
|
|
0 |
100 |
% | |||||||
|
|
|||||||||||
|
|
|
|
|
% |
| Signature | Digitally Signed By: John McManus |
Date | 4/15/2015 4:52:53 PM |